Norges Bank Cabaletta Bio, Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$6.39 - $11.28 $300,969 - $531,288	-47,100 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$6.0 - $18.67 $282,600 - $879,357	47,100 New	47,100 $344,000
Q1 2020 May 08, 2020	SELL	$6.0 - $18.67 $390,000 - $1.21 Million	-65,000 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$7.88 - $17.71 $512,200 - $1.15 Million	65,000 New	65,000 $908,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.